The top recommended treatment for high-risk outpatients with COVID-19 in the NIH Guidelines is nirmatrelvir/r (Paxlovid). It’s quite clear why. In the EPIC-HR study, unvaccinated people at high risk for severe outcomes had an 89% reduction in the risk for hospitalization or death compared to placebo. If we just look at mortality — another important endpoint, […]
Los Centros para el Control y la Prevención de Enfermedades (CDC) que es la agencia nacional de salud pública de los Estados Unidos advierten que hay un brote de enfermedad meningocócica en Florida. El Departamento de Salud del estado (FDOH) informa que en lo que corre del año 2022 los casos que se han identificado superan […]
The US Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to a first-of-its-kind test that can detect SARS-CoV-2 in the breath in less than 3 minutes. The COVID-19 Breathalyzer test (InspectIR Systems, LLC) will be available only in licensed test settings, therefore it is not currently meant […]
SARS-CoV-2, the virus that causes COVID-19, has continuously mutated since it emerged in late 2019. This rapid evolution poses challenges for vaccines and treatments designed to target the virus. A booster shot is now needed to produce antibodies to fight off the Omicron variant of SARS-CoV-2. And several combinations of […]
Merck’s drug was originally claimed to halve hospital admissions and deaths in people with covid-19, leading some governments to stockpile it as the pandemic continued. Andy Extance looks at the published evidence for its effectiveness What is molnupiravir? Molnupiravir (marketed as Lagevrio) is an antiviral drug, slightly modified from a compound known […]
The BA.2 variant, a subvariant of omicron, recently led to a surge in COVID cases in Europe, and now it is the dominant variant in the United States. This week also brought news of two new sub-lineages of BA.2—BA.2.12 and BA.2.12.1—in New York. Once again, we turned to our Institute for Health Metrics and […]
En pleno proceso de desescalada hacia la “normalidad” y justo cuando el Ministerio de Sanidad ha anunciado eliminar el uso de la mascarilla obligatoria en interiores a partir del próximo 19 de abril, la Organización Mundial de la Salud (OMS) ha informado de la aparición de una nueva variante de Covid conocida como XE. El […]
Healthy pet dogs and cats could be transmitting both antibiotic-resistant bacteria and genes involved in bacterial resistance to their owners, according to new research from the UK and Portugal. The preprint, but peer reviewed, study findings, to be presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases […]
Approximately 1 in 5 patients who presented with headache during the acute phase of COVID-19 developed chronic daily headache, according to a study published in the journal Cephalalgia. The greater the headache’s intensity during the acute phase, the greater the likelihood that it would persist. The research, carried out by members of the Headache Study Group […]
Artículo publicado en la revista Nature Medicine acerca de los resultados de la inoculación intranasal provocada con el virus SARS-CoV-2 en 36 voluntarios ingleses de 18 a 29 años sin evidencia de infección o vacunación, y cuyo objetivo primario era identificar la dosis vírica que inducía una infección bien tolerada en más […]
